- Nachrichtendetail
-
25.03.2024 12:13:46 - dpa-AFX: *REGENERON: FDA ISSUES CRLS FOR ODRONEXTAMAB BLA IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA AND R/R DIFFUSE LARGE B-CELL LYMPHOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 903,000 | 14.05.24 08:06:09 | +1,000 | +0,11% | 902,400 | 907,000 | 903,000 | 902,000 |
